1. Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis. (2nd January 2022) Authors: Johnston, Karissa; Popoff, Evan; Deighton, Alison; Dabirvaziri, Parisa; Harris, Linda; Thiry, Alexandra; Croop, Robert; Coric, Vladimir; L'Italien, Gilbert; Moren, James Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 22:Number 1(2022) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗